医疗基因组分析公司Bionano Genomics(BNGO)今日盘中大幅下跌6.48%,引发市场关注。
消息面上,BNGO最新财报数据显示营收同比增长但仍处于亏损状态,公司获利能力依然不佳。其营业收入为6.07百万美元,净利润亏损4425万美元,每股亏损30.92美元。公司近期盈利情况不理想或是导致股价下跌的主要原因。
此外,BNGO所属的医疗器械板块当日整体表现不佳,多只个股出现不同程度的下跌。整体市况低迷或也对该股价格造成一定压力。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.